Search

agbiopro
- Apr 28, 2019
- 0 min read

AbbVie hands Voyager a mega-billions gene therapy deal, with $310M in near-term cash

Recent Posts

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation